BIOMAT Database Logo BIOMAT Database Logo

[Evaluation of the anti-arrhythmia effectiveness of Phenazolinum Polfa in paroxysmal atrial fibrillation]. 1990

M Srzednicki, and Z Sadowski, and A Kulikowski
Kliniki Choroby Wieńcowej Instytutu Kardiologii w Warszawie.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000865 Antazoline An antagonist of histamine H1 receptors. Imidamine,Phenazoline,Analergine,Antasten,Antazoline Hydrochloride,Antazoline Phosphate,Antazoline Phosphate (1:1),Antistine,Arithmin,Hydrochloride, Antazoline,Phosphate, Antazoline

Related Publications

M Srzednicki, and Z Sadowski, and A Kulikowski
[Effectiveness of anti-arrhythmia agents in atrial fibrillation paroxysms].
June 1980, Klinicheskaia meditsina,
M Srzednicki, and Z Sadowski, and A Kulikowski
[Comparative evaluation of biological availability and anti-arrhythmia effectiveness of Mexicard (mexiletine Polfa)].
January 1989, Kardiologia polska,
M Srzednicki, and Z Sadowski, and A Kulikowski
[Supraventricular arrhythmia in patients with paroxysmal atrial fibrillation].
July 1988, Wiadomosci lekarskie (Warsaw, Poland : 1960),
M Srzednicki, and Z Sadowski, and A Kulikowski
[Therapy of paroxysmal atrial fibrillation. Cardiac glycosides alone or combined with anti-arrhythmia agents?].
December 1988, Deutsche medizinische Wochenschrift (1946),
M Srzednicki, and Z Sadowski, and A Kulikowski
[The efficacy of combinations of anti-arrhythmia preparations in patients with the paroxysmal form of atrial fibrillation].
January 1992, Terapevticheskii arkhiv,
M Srzednicki, and Z Sadowski, and A Kulikowski
Arrhythmia mechanism dependent pulmonary vein ablation in paroxysmal atrial fibrillation.
January 2023, Frontiers in physiology,
M Srzednicki, and Z Sadowski, and A Kulikowski
[Innovations in anti-arrhythmia therapy of atrial fibrillation].
December 2010, Herzschrittmachertherapie & Elektrophysiologie,
M Srzednicki, and Z Sadowski, and A Kulikowski
[Paroxysmal atrial fibrillation: which patients need anti-arrhythmia drugs?. Interview by Dr. med. Ulrike Hennemann].
August 1996, Fortschritte der Medizin,
M Srzednicki, and Z Sadowski, and A Kulikowski
[Problems with anti-arrhythmia therapy in atrial fibrillation].
January 1994, Zeitschrift fur Kardiologie,
M Srzednicki, and Z Sadowski, and A Kulikowski
Do Statins Decrease the Arrhythmia Burden in Patients with Paroxysmal Atrial Fibrillation?
December 2008, Journal of atrial fibrillation,
Copied contents to your clipboard!